Oklahoma's enacted law allows people and organizations to handle opioid overdose drugs and provides legal protections, but its text gives conflicting effective dates.
Any person may keep, buy, receive, share, or give an FDA-approved drug that blocks opioids' effects, including naloxone. Sharing must follow federal law; giving it requires a good-faith belief that someone is overdosing.
A person cannot be criminally prosecuted for possessing, storing, acquiring, sharing, making available, or giving an emergency opioid overdose drug under this section.
A person who shares, makes available, or gives an emergency opioid overdose drug in good faith is protected from civil damages, except for gross negligence or willful or wanton wrongdoing.
Any person may possess, store, acquire, distribute, make available, or administer an emergency opioid antagonist. An emergency opioid antagonist is an FDA-approved drug that blocks opioids' effects, including naloxone. “Person” includes individuals and legal entities such as businesses, governments, tribal entities, and colleges. Distribution or making the drug available must follow applicable federal law. A person may administer the drug when they believe in good faith that someone is experiencing an opioid overdose. The text gives July 1, 2026, as the effective date, but also says the law takes effect after passage and approval.
A person handling an emergency opioid antagonist under this section cannot be criminally prosecuted for that conduct. The protection covers possessing, storing, acquiring, distributing, making available, or administering the drug under this section. The text gives July 1, 2026, as the effective date, but also says the law takes effect after passage and approval.
A person who in good faith distributes, makes available, or administers an emergency opioid antagonist is protected from civil damages, subject to exceptions. The protection applies to distributing, making available, or administering the drug under this section. The protection does not cover acts or omissions that amount to gross negligence or willful or wanton wrongdoing in distributing, making available, or administering the drug. The text gives July 1, 2026, as the effective date, but also says the law takes effect after passage and approval.
No hearings or votes scheduled.